律师在调查听证会上表示，由于对最脆弱患者不当使用 Oxevision 系统，“患者的生命岌岌可危”。
因英格兰一半精神病病房使用的一种针对弱势患者的“侵入性”摄像头监控系统被滥用而失去亲人的家属，呼吁禁止该系统以帮助防止更多可避免的死亡。
Lawyers tell inquiry ‘patients’ lives are at stake’ through improper use of Oxevision system for most vulnerable Families bereaved by the misuse of an “intrusive” camera monitoring system for vulnerable patients used in half of England’s mental health wards, have called for it to be banned to help prevent more avoidable deaths.
周二，在对埃塞克斯郡精神健康死亡案件进行的兰帕德调查听证会上，家属代理律师称，Oxevision 系统的持续使用让“患者的生命岌岌可危”。
Lawyers for the families said “patients’ lives are at stake” by the continuing use of Oxevision, the Lampard inquiry into mental health deaths in Essex heard on Tuesday.
调查获悉，在埃塞克斯郡合作大学国家医疗服务体系基金会信托机构（Eput），两年内有五名患者在 Oxevision 红外摄像头的监控下自杀或意外死亡。
The inquiry was told that five patients killed themselves, or died unexpectedly, in two years while being surveilled by Oxevision’s infrared cameras at Essex Partnership University NHS foundation trust (Eput).
代理 70 多个丧亲家属（包括 2021 年因工作人员静音 Oxevision 报警系统而自杀身亡的 16 岁少女 Elise Sebastian 的家属）的大律师 Peter Mant 表示：“这项技术的使用因系统被误用，在实质性方面导致了患者受害，并在一些情况下导致患者死亡。”
Peter Mant KC, representing more than 70 bereaved families, including the family of Elise Sebastian, 16, who killed herself in 2021 when staff had muted Oxevision’s alarm system, said: “Use of this technology has contributed in material ways to harms, and in some cases deaths of patients, due to the misapplication of the system.”
代理包括 Sophie Alderman 家属在内的其他丧亲家属的大律师 Brenda Campbell 对调查主席 Kate Lampard 说：“我们敦促您建议在全国范围内停止在精神病住院病房使用 Oxevision。”
Addressing Kate Lampard, the chair of the inquiry, Brenda Campbell KC, representing other bereaved families including that of Sophie Alderman who the inquiry heard mistakenly believed in 2022 that Oxevision would bring staff to save her, said: “We urge you to recommend that the use of Oxevision on mental health inpatient wards is stopped nationally.”
她补充道：“其危害主要落在被强制收治、受创伤和神经发育差异患者身上，且没有任何监管机构为此承担责任。”
She added: “Its harms have fallen hardest on detained, traumatised and neurodivergent patients, and no regulator took responsibility for it.”